| Literature DB >> 22593770 |
Cider Asa1, Schaufelberger Maria, Stibrant Sunnerhagen Katharina, Andersson Bert.
Abstract
Background. Peak oxygen uptake (VO(2peak)) and muscle function are more decreased in patients with a combination of chronic heart failure (CHF) and type 2 diabetes mellitus (2DM) compared to patients with only one of the conditions. Further, patients with 2DM have peripheral complications that hamper many types of conventional exercises. Aim. To evaluate the efficacy and applicability of eight-week aquatic exercise in patients with the combination of CHF and 2DM. Methods. Twenty patients (four women) with both CHF and 2DM (age 67.4 ± 7.1, NYHA II-III) were randomly assigned to either aquatic exercise or a control group. The patients exercised for 45 minutes 3 times/week in 33-34°C, swimming pool. Results. The training programme was well tolerated. Work rate (+11.7 ± 6.6 versus -6.4 ± 8.1 watt, P < 0.001) and VO(2peak) (+2.1 ± 0.8 versus -0.9 ± 1.4 mL·kg(-1)·min(-1), P < 0.001) and walking capacity (P = 0.01) increased significantly in the training group. Muscle function was also significantly improved and Hba1c decreased significantly (P < 0.01) during training, while fasting glucose, insulin, c-peptide, and lipids were unchanged . Training also increased vitality measured by SF-36 significantly (P = 0.05). Conclusion. Aquatic exercise could be used to improve exercise capacity and muscle function in patients with the combination of CHF and 2DM.Entities:
Year: 2012 PMID: 22593770 PMCID: PMC3347725 DOI: 10.1155/2012/349209
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1The inclusion process of patients.
Demographic data of patients with chronic heart failure and type 2 diabetes mellitus.
| Variables | Training | Control |
|
|---|---|---|---|
| Age (years) | 65.8 ± 5.8 | 69 ± 8.2 | ns |
| Sex (F/M) | 2/8 | 2/8 | ns |
| Weight (kg) | 93.6 ± 16.2 | 86.6 ± 24.2 | ns |
| Height (cm) | 176.1 ± 10 | 174 ± 8.8 | ns |
| Duration of CHF (years) | 5.3 ± 2.6 | 6.0 ± 5.2 | ns |
| Duration of 2DM (years) | 7.2 ± 5.8 | 6.9 ± 4.4 | ns |
| LVEF (%) | 34.1 ± 9.8 | 34.8 ± 9.1 | ns |
| Etiology of CHF (IHD/DCM/HT) | 8/1/1 | 4/4/2 | ns |
| NYHA class (II/III) | 5/5 | 3/7 | ns |
| Chronic atrial fibrillation ( | 5 | 3 | ns |
| Beta blockers ( | 9 | 8 | ns |
| ACE-inhibitors ( | 8 | 9 | ns |
| Diuretics ( | 9 | 9 | ns |
| Digitalis ( | 2 | 5 | ns |
| Insulin ( | 5 | 3 | ns |
| Anti diabetics ( | 5 | 8 | ns |
| Acetyl-salicylic acid ( | 5 | 8 | ns |
| Warfarin ( | 5 | 3 | ns |
F/M: female and male, LVEF: left ventricular ejection fraction, NYHA: New York Heart Association classification, IHD: ischemic heart disease, DCM: dilated cardiomyopathy, HT: hypertension, ACE: angiotensin converting enzyme, n: number, ns: not significant.
Figure 2Work rate (a), peak oxygen uptake VO2peak (b), and distance walked (c) in six minute walk test before □ (n = 10 and 10) and after ■ (n = 8 and 9) eight weeks of aquatic exercise.
Muscle function before and after aquatic exercise in patients with chronic heart failure and type 2 diabetes mellitus.
| Knee extension in Biodex III. Isokinetic | Before ( | After ( |
|
| |
|---|---|---|---|---|---|
| Peak torque (60°s Nm) right leg | T | 122 ± 41 | 127 ± 34 | ns | ns |
| C | 102 ± 30 | 98 ± 32 | ns | ||
| Peak torque (180°s Nm) right leg | T | 88 ± 28 | 119 ± 54 | 0.02 | <0.001 |
| C | 66 ± 22 | 64 ± 24 | ns | ||
| Endurance decline in %, left leg | T | 46 ± 17 | 44 ± 13 | ns | ns |
| C | 51 ± 14 | 52 ± 16 | ns | ||
| Isometric | |||||
| Peak torque | T | 136 ± 41 | 136 ± 40 | ns | ns |
| 60° (N) right leg | C | 109 ± 37 | 101 ± 32 | ns | |
| Hand strength | |||||
| Peak force (N) | T | 342 ± 121 | 385 ± 106 | ns | ns |
| Right hand | C | 248 ± 82 | 221 ± 62 | 0.04 | |
| Peak force 10 s (N) | T | 289 ± 108 | 323 ± 89 | ns | ns |
| Right hand | C | 207 ± 77 | 187 ± 62 | ns | |
| Clinical endurance tests | |||||
| Heel lift (n.o) | T | 14 ± 7 | 18 ± 6 | 0.01 | 0.01 |
| C | 14 ± 4 | 14 ± 5 | ns | ||
| Shoulder flexion (n.o) | T | 26 ± 11* | 36 ± 12 | 0.02 | 0.03 |
| C | 17 ± 8 | 17 ± 28 | ns | ||
| Shoulder abduction (s) | T | 75 ± 25 | 89 ± 27 | 0.01 | <0.001 |
| C | 64 ± 26 | 56 ± 22 | 0.03 |
T: Training group, C: control group, ns: not significant, n.o.: number of, *: P ≤ 0.05 at baseline between training and control group.
Metabolic function before and after aquatic exercise in patients with chronic heart failure and type 2 diabetes mellitus.
| Variables | Before ( | After |
|
| |
|---|---|---|---|---|---|
| Hba1c (%) | T | 7.9 ± 2.9 | 7.2 ± 0.9 | 0.01 | ns |
| C | 6.9 ± 2.0 | 6.7 ± 3.2 | ns | ||
| P-Fasting glucos (mmol/L) | T | 10.2 ± 2.9 | 9.3 ± 2.6 | ns | ns |
| C | 7.8 ± 3.3 | 6.9 ± 2.0 | ns | ||
| S-Insulin (mU/L) | T | 20 ± 5.7 | 20.1 ± 11.5 | ns | ns |
| C | 19.2 ± 14.9 | 16.1 ± 14.0 | ns | ||
| S-C-peptide (nmol/L) | T | 0.8 ± 0.4 | 1.1 ± 0.5 | ns | ns |
| C | 1.0 ± 0.9 | 1.4 ± 1.5 | ns | ||
| S-Triglycerides (mmol/L) | T | 2.4 ± 3.4 | 2.2 ± 2.1 | ns | ns |
| C | 1.9 ± 1.0 | 1.6 ± 0.8 | ns | ||
| S-Cholesterol (mmol/L) | T | 4.2 ± 1.0 | 4.3 ± 0.9 | ns | ns |
| C | 4.2 ± 1.1 | 4.1 ± 0.5 | ns |
P: plasma, S: serum, T: Training group, C: control group.
Figure 3(a) Scores of SF-36 in all patients with chronic heart failure and type 2 diabetes mellitus, ■, (n = 20) compared to a Swedish healthy reference population -◊-. (b) Change in SF-36 after aquatic exercise, training group, ■, (n = 8) control group, □, (n = 9)*, P = 0.05.
No significant changes in disease specific quality of life and grade of anxiety and depression occurred after eight weeks of aquatic exercise.
| LHFQ | Before ( | After ( | HAD | Before ( | After ( | |
|---|---|---|---|---|---|---|
| Total score | T | 48 ± 22 | 43 ± 15 | Anxiety | 5.1 ± 4.8 | 5.4 ± 3.7 |
| C | 35 ± 13 | 35 ± 16 | 3.1 ± 1.8 | 3.5 ± 3.0 | ||
| Physical dimension | T | 22 ± 14 | 16 ± 8 | Depression | 3.5 ± 3.2 | 3.6 ± 2.3 |
| C | 19 ± 11 | 20 ± 13 | 4.2 ± 2.7 | 4.9 ± 3.7 | ||
| Emotional dimension | T | 10 ± 8 | 7 ± 6 | |||
| C | 5 ± 4 | 5 ± 4 |
LHFQ: Minnesota living with heart failure questionnaire HAD: hospital anxiety and depression scale. T: Training group, C: control group.